CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

(Colorado State University) SolaVAX repurposes a commercial platform that is currently used to inactivate pathogens in blood transfusions.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news